DeepMed Research

ALLAYSIS, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Repeated Dose IV Baclofen Safety/Bioequivalence Study

Phase 1

Conditions: Intravenous Baclofen

Interventions: Drug: Oral Baclofen
Drug: IV Baclofen

First Posted Date: 2016-05-04

Last Posted Date: 2016-11-29

Lead Sponsor: Allaysis, LLC

Target Recruit Count: 42

Registration Number: NCT02760992

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy